Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Polvitolimod [inn]
2. 2389988-81-0
3. 84sv793nfk
4. 2-amino-9-[(2r,3s,4s,5r)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynylpurin-8-one
5. 8h-purin-8-one, 2-amino-9-(3-deoxy-3-fluoro-beta-d-ribofuranosyl)-7,9-dihydro-7-(2-propyn-1-yl)-
6. Compound 32 [wo2019226977a1]
7. 2-amino-9-(3-deoxy-3-fluoro-beta-d-ribofuranosyl)-7-(prop-2-yn-1-yl)-7,9-dihydro-8h-purin-8-one
8. 2-amino-9-(3-deoxy-3-fluoro-.beta.-d-ribofuranosyl)-7-(prop-2-yn-1-yl)-7,9-dihydro-8h-purin-8-one
9. 8h-purin-8-one, 2-amino-9-(3-deoxy-3-fluoro-.beta.-d-ribofuranosyl)-7,9-dihydro-7-(2-propyn-1-yl)-
10. Compound 32 (wo2019226977a1)
11. 2-amino-9-((2r,3s,4s,5r)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-7-prop-2-ynylpurin-8-one
12. Refchem:175049
13. Unii-84sv793nfk
14. Orb1689158
15. Schembl23202027
16. Schembl31142238
17. Gtpl11872
18. Glxc-26965
19. Da-76975
20. Hy-145618
21. Cs-0376782
| Molecular Weight | 323.28 g/mol |
|---|---|
| Molecular Formula | C13H14FN5O4 |
| XLogP3 | -1.7 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 3 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 125 |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 528 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE